Pharmaceutical Product Monograph: Artemether Injection

In the pharmaceutical industry, Artemether is a lipid-soluble methyl ether derivative of artemisinin. As a pharmacist and manufacturer, I view this molecule as a “Second-Line Parenteral Antimalarial”—while Artesunate is the preferred first-line choice for severe malaria due to its water solubility, Artemether remains a critical alternative for intramuscular (IM) use in settings where intravenous (IV) access or artesunate is unavailable.

At your WHO-GMP facility in Mumbai, Artemether is typically manufactured as an oil-based injectable to ensure stability and sustained release.

Types & Formulations of Artemether Injections

Artemether is technically restricted to the intramuscular route because it is insoluble in water. There are two primary presentations based on the patient’s age and weight:

1. Adult Strength (80 mg/mL)

• Composition: 80 mg of Artemether dissolved in 1 mL of an oily vehicle (typically Arachis/Peanut oil or Sesame oil).

• Presentation: Clear, pale yellow oily solution in 1 mL or 2 mL amber glass ampoules.

• Usage: For adults and older children requiring higher dosage volumes.

2. Pediatric Strength (40 mg/0.5 mL)

• Composition: 40 mg of Artemether in 0.5 mL of oil.

• Technical Rationale: Using a smaller volume (0.5 mL) is a manufacturer’s best practice for pediatric use to minimize injection site pain and ensure more accurate dosing for infants.

3. Artemether + Lumefantrine (Ready-to-Use Combinations)

• While Artemether-Lumefantrine is most famous as an oral tablet (ACT), specialized injectable combinations exist for severe cases, though they are less common than the standalone oily Artemether injection.

Comparison: Artemether vs. Artesunate (The “Solubility” Factor)

From a technical manufacturing standpoint, the choice between these two determines the route of administration:

Mechanism: The Endoperoxide “Bomb”

Artemether works by releasing toxic free radicals specifically inside the malaria parasite.

Heme Interaction: The drug enters the infected red blood cell and reacts with the heme (iron) produced by the parasite’s digestion of hemoglobin.

Free Radical Release: This reaction breaks the drug’s endoperoxide bridge, creating “free radicals.”

Protein Alkylation: These radicals attack the parasite’s cell membranes and proteins, causing rapid death of the schizont (blood stage) of P. falciparum.

The Pharmacist’s “Technical Warning”

• Never Give IV: As a pharmacist, I must warn that oil-based injections like Artemether must never be given intravenously. Doing so can cause a fatal fat embolism.

• The “Oil” Allergy: Check for allergies to the vehicle. Many formulations use Peanut Oil (Arachis Oil); patients with nut allergies must be monitored or given an alternative.

• Delayed Absorption: In patients with shock or severe dehydration, IM absorption of an oily drug can be erratic. In these cases, IV Artesunate is technically superior.

• Pregnancy: Artemether is generally avoided in the first trimester of pregnancy unless no other life-saving alternative is available.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

• The “Nitrogen Blanketing” USP: On your digital marketplace, highlight that your ampoules are filled under Nitrogen gas. Artemether is sensitive to oxidation; removing oxygen from the headspace is a technical requirement for a 36-month shelf life.

• Stability for Export: Oily injections are highly stable in tropical climates. This makes Artemether an excellent SKU for your African and Southeast Asian B2B portfolios where “cold chain” logistics might be inconsistent.

• Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for both 40 mg and 80 mg Artemether injections to support your firm’s registration in international public health tenders.